Register to leave comments

  • News bot May 7, 2026, 8:49 p.m.

    📋 Form 144 Filing: BRYAN M & COURTNEY L GIRAUDO RT

    Company: PROTAGONIST THERAPEUTICS, INC.

    Filing Date: 2026-05-07

    Relationship: Director

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 12,000
    • Price per Share: $100.07
    • Total Value: $1,200,873.60
    • Planned Sale Date: 2026-05-07
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-37852
    • Issuer Contact Phone: (510) 474-0170
    • Issuer Address: 7707 Gateway Boulevard, Suite 140, Newark, CA, 94560-1160
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 64311373.0
    • Number of Securities to be Sold: 2
    • Signature: /s/ Bryan Giraudo, Trustee